AOD-9604 5mg is a modified HGH fragment research peptide studied for its role in lipolysis, fat metabolism, and energy regulation pathways. In laboratory settings, AOD-9604 is widely used in research focused on adipose tissue signaling, metabolic efficiency, and fat breakdown models.
For Research Use Only. Not for human use.
AOD9604 is a modified analogue of the hGH C-terminal fragment (residues 177–191 with N-terminal tyrosine addition and disulfide cyclisation), first synthesized in the 1990s by Metabolic Pharmaceuticals. It has been studied for its selective stimulation of lipolysis via beta-3 adrenergic receptor upregulation in adipose tissue without elevating IGF-1 or producing hGH-like anabolic side effects. This research-grade lyophilized powder is synthesized under strict quality controls and includes full analytical documentation, making it suitable for metabolic, lipolytic, and cartilage repair research applications.
Key Scientific Features
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
Why Researchers Choose Nationwide Peptides AOD9604
| Product Name | AOD-9604 Peptide |
|---|---|
| Avg Purity | ≥99% |
| Chemical Data | CAS: 221231-10-3; Formula: C₇₈H₁₂₃N₂₃O₂₃S₂; Molecular Weight: approximately 1815.1 g/mol |
| Format | Lyophilized freeze-dried peptide powder |
| Quantity | 5mg per vial |
| Packaging | Sealed research vial with batch label, protective carton |
